Bilirubin in clinical practice: a review

J Fevery - Liver International, 2008 - Wiley Online Library
Bilirubin is an endogenous compound that can be toxic under certain conditions but, on the
other hand, mild unconjugated hyperbilirubinaemia might protect against cardiovascular …

Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in …

K Kurose, E Sugiyama, Y Saito - Drug metabolism and …, 2012 - jstage.jst.go.jp
Drug lag, recently discussed extensively in Japan, can be divided into two phases: clinical
development time and application review time. The former factor is still an important problem …

[HTML][HTML] Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol

F Meric-Bernstam, L Brusco, M Daniels, C Wathoo… - Annals of …, 2016 - Elsevier
Background Next-generation sequencing in cancer research may reveal germline variants
of clinical significance. We report patient preferences for return of results and the prevalence …

[HTML][HTML] Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years

M Panczyk - World Journal of Gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
During the past two decades the first sequencing of the human genome was performed
showing its high degree of inter-individual differentiation, as a result of large international …

UGT1A1 Haplotypes Associated with Reduced Glucuronidation and Increased Serum Bilirubin in Irinotecan‐administered Japanese Patients with Cancer

K Sai, M Saeki, Y Saito, S Ozawa… - Clinical …, 2004 - Wiley Online Library
Purpose A comprehensive haplotype analysis of UGT1A1 in the Japanese population was
conducted, and the effects of these haplotypes were investigated with respect to UGT1A1 …

Pharmacogenetics of irinotecan metabolism and transport: an update

NF Smith, WD Figg, A Sparreboom - Toxicology in vitro, 2006 - Elsevier
The anticancer agent irinotecan (CPT-11) is converted to SN-38, which is approximately 100
to 1000-fold more cytotoxic than the parent drug. The pharmacokinetics of irinotecan are …

Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer

S Nagar, RP Remmel - Oncogene, 2006 - nature.com
The uridine diphosphoglucuronosyltransferases (UGTs) belong to a superfamily of enzymes
that catalyse the glucuronidation of numerous endobiotics and xenobiotics. Several human …

Pharmacological inhibition of bacterial β-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo

KW Cheng, CH Tseng, CC Tzeng, YL Leu… - Pharmacological …, 2019 - Elsevier
Abstract Irinotecan (CPT-11), a first-line chemotherapy for advanced colorectal cancer,
causes serious diarrhea in patients receiving treatment. The underlying mechanism has …

An appraisal of drug-drug interactions with green tea (Camellia sinensis)

AA Albassam, JS Markowitz - Planta medica, 2017 - thieme-connect.com
This review summarizes published in vitro, animal, and clinical studies investigating the
effects of green tea (Camellia sinensis) extract and associated catechins on drug …

[HTML][HTML] FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study

IR Cho, H Kang, JH Jo, HS Lee, MJ Chung… - World journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND FOLFIRINOX and gemcitabine plus nab-paclitaxel (Gem+ nabPTX) were
recently introduced for metastatic pancreatic cancer treatment. However, studies that …